// Reference=Talairach		// (3) Thiel, 2005: NIC > PLAC (reorienting)		// Subjects=15		-26.57	-44.16	34.78-29.3	-13.67	40.326.69	1.87	53.2126.91	-44.54	-21.11-37.31	-52.41	4.09-42.69	0.98	6.35-9.18	-16.92	-13.7-3.69	-66.74	-23.737.56	-52.04	-30.25		// (7) Tanabe, 2011: NIC(post) > PLAC(pre) (resting ACTIVITY)		// Subjects=19		-51.19	-61.48	1.19-48.5	-68.54	5.97-42.89	-69.91	0.5343.05	-65.81	13.1845.92	-56.92	8.67		// (8) Kumari, 2003: NIC > PLAC, (0-back)		// Subjects=11		6	-5	40		// (8) Kumari, 2003: NIC > PLAC, (1-back)		// Subjects=11		5	0	4051	2	41-51	4	3656	-43	39-53	-45	3924	-60	-28		// (8) Kumari, 2003: NIC > PLAC, (2-back)		// Subjects=11		6	0	4351	2	41-51	2	3756	-43	39-53	-45	39		// (8) Kumari, 2003: NIC > PLAC, (3-back)		// Subjects=11		46	-1	49-44	-52	51		// (14) Tregellas, 2011: NIC > PPLAC, (smooth pursuit task)		// Subjects=15		12.13	-70.3	41.06-12.84	-48.07	45.45		// (37) Kobiella, 2010: NIC > PLAC, (emotional processing)(negative-neutral)		// Subjects=31		-22.93	-1.25	-19.65-29.15	-9.83	29.8815.19	3.98	40.95-17.57	48.45	10.3710.14	29.68	9.06-23.64	26.36	44.21-1.89	-8.21	70.1331.74	15.89	53.1611.51	22.46	44.44-34.36	43.94	18.67-23.01	10.92	-9.4934.41	20.11	-9.45-34.22	-28.15	-13.3832.41	-21.22	-9.810.16	9.7	1.7618.98	-22.77	25.862.58	-31.77	3.11-31.02	-33.69	23.98-34.34	-3.46	3.37-58.3	-37.34	-14.6656.43	-6.96	-2.63-27.9	-52.62	63.6846.4	-41.95	47.933.59	-69.03	57.2532.63	-34.2	-30.84		// (38) Evans, 2013a: NIC > PLAC, (spatial attentionl)(inv trials only, all ppants)		// Subjects=36		24.71	40.64	31.07		// (39) Evans, 2013b: NIC > PLAC, (prospective memory)(main effect nic)		// Subjects=40		5.75	-46.71	40.4952.21	-47.34	25.9		// (39) Evans, 2013b: NIC > PLAC, (prospective memory)(e4+ only, PM trials) (genoypexdrug)		// Subjects=20		4.05	-82.14	18.18		// (39) Evans, 2013b: NIC > PLAC, (prospective memory)(e4+ only, nicPM>placPM) (genoypexdrugxtrial)		// Subjects=20		28.88	-16.25	-22		